As Chief Commercial Officer at Nucleus RadioPharma, Kathy Spencer-Pike brings over 20 years of experience in Fortune 50 companies and fast-growing startups. Before joining Nucleus RadioPharma, she was Chief Sales Officer at McKesson. Previously, as VP, Commercial Leader at Novo Nordisk, she led market and sales strategies and also held leadership roles at Sanofi and Pfizer, managing sales, marketing, and operations. Kathy holds a B.S. in Elementary Education from Eastern Kentucky University and an M.A. in Mental Health Counseling from Webster University.
From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out